-
1 Comment
Autek China Inc is currently in a long term uptrend where the price is trading 46.9% above its 200 day moving average.
From a valuation standpoint, the stock is 625.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 69.9.
Autek China Inc's total revenue rose by 63.1% to $264M since the same quarter in the previous year.
Its net income has increased by 101.0% to $156M since the same quarter in the previous year.
Finally, its free cash flow grew by 105.4% to $95M since the same quarter in the previous year.
Based on the above factors, Autek China Inc gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100002MR0 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | 13B |
|---|---|
| PE Ratio | 22.91 |
| Target Price | 19.27 |
| Dividend Yield | 1.5% |
| Beta | 1.08 |
Autek China Inc. provides eye health and myopia prevention, and control technology and services in China. The company operates through Ophthalmology Services; and Products segments. It also offers ophthalmic and optometry medical devices. In addition, the company provides ophthalmic optometry technology services, as well as operates various eye care hospitals. Autek China Inc. was founded in 2000 and is based in Hefei, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300595.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
